Table 2.
Regression analyses
| Any antimalarial | AL | Antibiotic | ORS | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |||||||||||||
| Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | |
| Constant | −0.285** | −0.624** | −0.285** | −0.625** | −0.285** | −0.611** | −0.587*** | −1.097*** | −0.587*** | −1.100*** | −0.587*** | −1.088*** | 0.869*** | 0.951** | 0.869*** | 0.947** | 0.869*** | 0.949** | −0.613*** | −0.975** | −0.613*** | −0.929** | −0.613*** | −0.925** |
| (0.116) | (0.255) | (0.116) | (0.254) | (0.116) | (0.253) | (0.092) | (0.247) | (0.092) | (0.244) | (0.092) | (0.244) | (0.160) | (0.445) | (0.160) | (0.446) | (0.160) | (0.446) | (0.175) | (0.417) | (0.175) | (0.424) | (0.175) | (0.424) | |
| Intervention | −0.222 | −0.188 | −0.222 | −0.187 | −0.222 | −0.188 | −0.010 | 0.026 | −0.010 | 0.029 | −0.010 | 0.028 | −0.199 | −0.513** | −0.199 | −0.513** | −0.199 | −0.513** | 0.208 | 0.121 | 0.208 | 0.116 | 0.208 | 0.113 |
| (0.180) | (0.169) | (0.180) | (0.169) | (0.180) | (0.169) | (0.170) | (0.163) | (0.170) | (0.163) | (0.170) | (0.163) | (0.234) | (0.245) | (0.234) | (0.245) | (0.234) | (0.245) | (0.261) | (0.268) | (0.261) | (0.268) | (0.261) | (0.269) | |
| Post Intervention | 0.045 | 0.019 | 0.252* | 0.230* | −0.420** | −0.453** | 0.315 | 0.339 | ||||||||||||||||
| (0.156) | (0.156) | (0.133) | (0.138) | (0.211) | (0.213) | (0.219) | (0.230) | |||||||||||||||||
| Intervention* Post-Intervention | 0.590** | 0.565** | 0.588** | 0.560** | 0.374* | 0.335 | 0.364 | 0.323 | −0.123 | −0.078 | −0.133 | −0.087 | −0.339 | −0.297 | −0.298 | −0.251 | ||||||||
| (0.234) | (0.224) | (0.235) | (0.225) | (0.222) | (0.216) | (0.223) | (0.217) | (0.306) | (0.307) | (0.308) | (0.308) | (0.298) | (0.302) | (0.305) | (0.309) | |||||||||
| year 2015 | 0.026 | −0.014 | −0.085 | −0.123 | 0.172 | 0.132 | 0.082 | 0.042 | −0.329 | −0.362 | −0.379 | −0.395 | 0.543** | 0.582** | 0.392 | 0.422* | ||||||||
| (0.176) | (0.177) | (0.206) | (0.209) | (0.146) | (0.152) | (0.166) | (0.173) | (0.249) | (0.246) | (0.270) | (0.274) | (0.228) | (0.236) | (0.243) | (0.253) | |||||||||
| year 2016 | 0.062 | 0.051 | 0.169 | 0.157 | 0.328** | 0.324** | 0.413** | 0.410** | −0.488** | −0.524** | −0.451* | −0.500** | 0.046 | 0.051 | 0.227 | 0.251 | ||||||||
| (0.164) | (0.163) | (0.176) | (0.175) | (0.151) | (0.155) | (0.170) | (0.174) | (0.221) | (0.227) | (0.233) | (0.233) | (0.244) | (0.254) | (0.253) | (0.267) | |||||||||
| year 2015* Intervention | 0.794*** | 0.762*** | 0.529** | 0.488* | −0.054 | −0.036 | −0.002 | 0.070 | ||||||||||||||||
| (0.282) | (0.281) | (0.251) | (0.252) | (0.361) | (0.375) | (0.350) | (0.353) | |||||||||||||||||
| year 2016* Intervention | 0.409 | 0.384 | 0.223 | 0.179 | −0.197 | −0.130 | −0.612* | −0.597* | ||||||||||||||||
| (0.264) | (0.251) | (0.262) | (0.253) | (0.374) | (0.359) | (0.332) | (0.341) | |||||||||||||||||
| N | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 1036 | 1036 | 1036 | 1036 | 1036 | 1036 | 1552 | 1552 | 1552 | 1552 | 1552 | 1552 |
| Log-Likelihood | −1963 | −1922 | −1963 | −1921 | −1961 | −1919 | −1939 | −1893 | −1938 | −1891 | −1937 | −1889 | −679 | −653 | −678 | −652 | −678 | −652 | −1041 | −1022 | −1033 | −1014 | −1031 | −1010 |
| AIC | 3935 | 3871 | 3937 | 3873 | 3935 | 3871 | 3887 | 3813 | 3886 | 3811 | 3885 | 3810 | 1365 | 1333 | 1366 | 1335 | 1368 | 1337 | 2090 | 2072 | 2077 | 2057 | 2073 | 2053 |
AL Artemether Lumefantrine, ORS Oral Rehydration Salts, Unadj unadjusted models, Adj models adjusted for child’s age and sex, care giver’s age and sex, level of education and marital status, and the household socioeconomic status (wealth index)
* p < 0.1; ** p < 0.05; *** p < 0.01